AbbVie Inc. v. Annora Pharma Private Limited
AbbVie v. Annora: When Generic Ambitions Meet Real-World Patent Risk
For years, the generic and biosimilar ecosystem has operated on a familiar rhythm: analyze the Orange Book (or its global equivalents), map exclusivities, stress-test patents, and pri…
